Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
- PMID: 35130127
- PMCID: PMC8824225
- DOI: 10.1080/19490976.2022.2031696
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
Abstract
Obesity and type 2 diabetes (T2D) are growing burdens for individuals and the health-care system. Bariatric surgery is an efficient, but drastic treatment to reduce body weight, normalize glucose values, and reduce low-grade inflammation. The gut microbiome, which is in part controlled by intestinal antibodies, such as IgA, is involved in the development of both conditions. Knowledge of the effect of bariatric surgery on systemic and intestinal antibody response is limited. Here, we determined the fecal antibody and gut microbiome response in 40 T2D and non-diabetic (ND) obese individuals that underwent bariatric surgery (N = 40). Body weight, fasting glucose concentrations and inflammatory parameters decreased after bariatric surgery, whereas pro-inflammatory bacterial species such as lipopolysaccharide (LPS), and flagellin increased in the feces. Simultaneously, concentrations of LPS- and flagellin-specific intestinal IgA levels increased with the majority of pro-inflammatory bacteria coated with IgA after surgery. Finally, serum antibodies decreased in both groups, along with a lower inflammatory tone. We conclude that intestinal rearrangement by bariatric surgery leads to expansion of typical pro-inflammatory bacteria, which may be compensated by an improved antibody response. Although further evidence and mechanistic insights are needed, we postulate that this apparent compensatory antibody response might help to reduce systemic inflammation by neutralizing intestinal immunogenic components and thereby enhance intestinal barrier function after bariatric surgery.
Keywords: Immunoglobulin; bariatric surgery; flagellin; gut microbiome; lipopolysaccharide.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures




Similar articles
-
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?Semin Immunopathol. 2019 Jul;41(4):461-475. doi: 10.1007/s00281-019-00738-3. Epub 2019 Apr 25. Semin Immunopathol. 2019. PMID: 31025085 Review.
-
Changes in Gut Microbiome after Bariatric Surgery Versus Medical Weight Loss in a Pilot Randomized Trial.Obes Surg. 2019 Oct;29(10):3239-3245. doi: 10.1007/s11695-019-03976-4. Obes Surg. 2019. PMID: 31256356 Clinical Trial.
-
Compensatory intestinal immunoglobulin response after vancomycin treatment in humans.Gut Microbes. 2021 Jan-Dec;13(1):1-14. doi: 10.1080/19490976.2021.1875109. Gut Microbes. 2021. PMID: 33475461 Free PMC article.
-
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296. Orv Hetil. 2016. PMID: 26708682 Review. Hungarian.
-
Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.Clin Sci (Lond). 2015 Dec;129(12):1083-96. doi: 10.1042/CS20150431. Clin Sci (Lond). 2015. PMID: 26464517 Review.
Cited by
-
The gut microbiome: a core regulator of metabolism.J Endocrinol. 2023 Jan 19;256(3):e220111. doi: 10.1530/JOE-22-0111. Print 2023 Mar 1. J Endocrinol. 2023. PMID: 36458804 Free PMC article. Review.
-
The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases.Front Microbiol. 2022 Aug 18;13:977187. doi: 10.3389/fmicb.2022.977187. eCollection 2022. Front Microbiol. 2022. PMID: 36060752 Free PMC article. Review.
-
Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation.Microorganisms. 2022 Dec 29;11(1):93. doi: 10.3390/microorganisms11010093. Microorganisms. 2022. PMID: 36677385 Free PMC article. Review.
-
Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality.Front Microbiol. 2022 Sep 20;13:1003755. doi: 10.3389/fmicb.2022.1003755. eCollection 2022. Front Microbiol. 2022. PMID: 36204626 Free PMC article. Review.
-
Diet Management of Patients with Chronic Kidney Disease in Bariatric Surgery.Nutrients. 2022 Dec 29;15(1):165. doi: 10.3390/nu15010165. Nutrients. 2022. PMID: 36615822 Free PMC article. Review.
References
-
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous